These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21623925)

  • 1. Infliximab partially impairs the anti-Mycobacterium tuberculosis immune responses of severe psoriasis patients with positive tuberculin skin-test.
    Silva LC; Geluk A; Arnone M; Romiti R; Franken KC; Duarte AJ; Takahashi MD; Benard G
    J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):319-24. PubMed ID: 21623925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decrease in Mycobacterium tuberculosis specific immune responses in patients with untreated psoriasis living in a tuberculosis endemic area.
    Silva LC; Silveira GG; Arnone M; Romiti R; Geluk A; Franken KC; Duarte AJ; Takahashi MD; Benard G
    Arch Dermatol Res; 2010 May; 302(4):255-62. PubMed ID: 19609541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infliximab does not lead to reduction in the interferon-gamma and lymphoproliferative responses of patients with moderate to severe psoriasis.
    Ortigosa LC; Silva LC; Duarte AJ; Takahashi MD; Benard G
    Acta Derm Venereol; 2014 Jan; 94(1):26-31. PubMed ID: 23824243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of enzyme-linked immunospot assay (Elispot) compared to tuberculin skin testing for latent tuberculosis screening in rheumatic patients scheduled for anti-tumor necrosis factor treatment.
    Vassilopoulos D; Stamoulis N; Hadziyannis E; Archimandritis AJ
    J Rheumatol; 2008 Jul; 35(7):1271-6. PubMed ID: 18381793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of an IFN-gamma assay in the diagnosis of latent tuberculosis in patients with psoriasis in a highly endemic setting.
    de Andrade Lima E; de Andrade Lima M; de Lorena VM; de Miranda Gomes Y; Lupi O; Benard G
    Acta Derm Venereol; 2011 Oct; 91(6):694-7. PubMed ID: 21629971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening of tuberculosis by interferon-gamma assay before biologic therapy for rheumatoid arthritis.
    Murakami S; Takeno M; Kirino Y; Kobayashi M; Watanabe R; Kudo M; Ihata A; Ueda A; Ohno S; Watanuki Y; Kaneko T; Ishigatsubo Y
    Tuberculosis (Edinb); 2009 Mar; 89(2):136-41. PubMed ID: 19211305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Characteristics of a diagnostic method for tuberculosis infection based on whole blood interferon-gamma assay].
    Harada N
    Kekkaku; 2006 Nov; 81(11):681-6. PubMed ID: 17154047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive conversion of tuberculin skin test and performance of interferon release assay to detect hidden tuberculosis infection during anti-tumor necrosis factor agent trial.
    Park JH; Seo GY; Lee JS; Kim TH; Yoo DH
    J Rheumatol; 2009 Oct; 36(10):2158-63. PubMed ID: 19723901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-γ release assay for tuberculosis in patients with psoriasis treated with tumour necrosis factor antagonists: in vivo and in vitro analysis.
    Sauzullo I; Mengoni F; Marocco R; Potenza C; Skroza N; Tieghi T; Lichtner M; Vullo V; Mastroianni CM
    Br J Dermatol; 2013 Nov; 169(5):1133-40. PubMed ID: 23909256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon gamma assay.
    Matulis G; Jüni P; Villiger PM; Gadola SD
    Ann Rheum Dis; 2008 Jan; 67(1):84-90. PubMed ID: 17644549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function.
    Bedini C; Nasorri F; Girolomoni G; Pità Od; Cavani A
    Br J Dermatol; 2007 Aug; 157(2):249-58. PubMed ID: 17489975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An in-house RD1-based enzyme-linked immunospot-gamma interferon assay instead of the tuberculin skin test for diagnosis of latent Mycobacterium tuberculosis infection.
    Codecasa L; Mantegani P; Galli L; Lazzarin A; Scarpellini P; Fortis C
    J Clin Microbiol; 2006 Jun; 44(6):1944-50. PubMed ID: 16757583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists.
    Hamdi H; Mariette X; Godot V; Weldingh K; Hamid AM; Prejean MV; Baron G; Lemann M; Puechal X; Breban M; Berenbaum F; Delchier JC; Flipo RM; Dautzenberg B; Salmon D; Humbert M; Emilie D;
    Arthritis Res Ther; 2006; 8(4):R114. PubMed ID: 16859506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of an in vitro tuberculosis interferon-gamma assay with delayed-type hypersensitivity testing for detection of latent Mycobacterium tuberculosis: a pilot study in rheumatoid arthritis.
    Greenberg JD; Reddy SM; Schloss SG; Kurucz OS; Bartlett SJ; Abramson SB; Bingham CO
    J Rheumatol; 2008 May; 35(5):770-5. PubMed ID: 18322990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immune response to Mycobacterium tuberculosis in HIV-infected and uninfected adults in Uganda: application of a whole blood cytokine assay in an epidemiological study.
    Elliott AM; Hurst TJ; Balyeku MN; Quigley MA; Kaleebu P; French N; Biryahwaho B; Whitworth JA; Dockrell HM; Hayes RJ
    Int J Tuberc Lung Dis; 1999 Mar; 3(3):239-47. PubMed ID: 10094326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients.
    Bourgarit A; Carcelain G; Martinez V; Lascoux C; Delcey V; Gicquel B; Vicaut E; Lagrange PH; Sereni D; Autran B
    AIDS; 2006 Jan; 20(2):F1-7. PubMed ID: 16511406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tuberculin skin test increases the responses measured by T cell interferon-gamma release assays.
    Vilaplana C; Ruiz-Manzano J; Gil O; Cuchillo F; Montané E; Singh M; Spallek R; Ausina V; Cardona PJ
    Scand J Immunol; 2008 Jun; 67(6):610-7. PubMed ID: 18397200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of QuantiFERON®-TB Gold test in psoriatic patients under treatment with tumour necrosis factor blockers.
    Saraceno R; Specchio F; Chiricozzi A; Sarmati L; Amicosante M; Chimenti MS; Chimenti S
    Expert Opin Biol Ther; 2014 Feb; 14(2):151-6. PubMed ID: 24303977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A T-cell-based enzyme-linked immunospot assay for tuberculosis screening in Chinese patients with rheumatic diseases receiving infliximab therapy.
    Xie X; Chen JW; Li F; Tian J; Gao JS; Zhang D
    Clin Exp Med; 2011 Sep; 11(3):155-61. PubMed ID: 21161670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.